Becoming a Clinical Trialist

Related

• 

  Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study

  W. Lloyd Clark, MD, FASRS

  Updates from the Field

  2022

• 

  The Great Resignation/Emerging From the Fog

  Scott D Walter, MD, MSc, FASRS

  Updates from the Field

  2023

• 

  Ethics in Retina: A Discussion on the Ethical Considerations in Industry Relationships and Informed Consent

  Nancy M. Holekamp, MD, FASRS

  J. Michael Jumper, MD, FASRS

  Paul Chan

  Adrienne W. Scott, MD, FASRS

  Webinars and Journal Clubs

  2017